DK0959899T3 - LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation - Google Patents

LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation

Info

Publication number
DK0959899T3
DK0959899T3 DK96930529T DK96930529T DK0959899T3 DK 0959899 T3 DK0959899 T3 DK 0959899T3 DK 96930529 T DK96930529 T DK 96930529T DK 96930529 T DK96930529 T DK 96930529T DK 0959899 T3 DK0959899 T3 DK 0959899T3
Authority
DK
Denmark
Prior art keywords
inhibit
proliferation
cd2a antibody
cell activation
cd2a
Prior art date
Application number
DK96930529T
Other languages
Danish (da)
English (en)
Inventor
Herve Bazin
Ruth Kaplan
Thomas Kieber-Emmons
Christina E Postema
Mary E White-Scharf
Dominique Latinne
Original Assignee
Biotransplant Inc
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc, Univ Catholique Louvain filed Critical Biotransplant Inc
Application granted granted Critical
Publication of DK0959899T3 publication Critical patent/DK0959899T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2806—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96930529T 1996-08-16 1996-08-16 LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation DK0959899T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/013281 WO1998007444A1 (fr) 1996-08-16 1996-08-16 ANTICORPS LO-CD2a ET SON UTILISATION POUR INHIBER L'ACTIVATION ET LA PROLIFERATION DE CELLULES T

Publications (1)

Publication Number Publication Date
DK0959899T3 true DK0959899T3 (da) 2009-09-07

Family

ID=22255617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930529T DK0959899T3 (da) 1996-08-16 1996-08-16 LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation

Country Status (10)

Country Link
EP (1) EP0959899B9 (fr)
JP (1) JP2001521374A (fr)
AT (1) ATE432080T1 (fr)
AU (1) AU737602B2 (fr)
CA (1) CA2262546C (fr)
DE (1) DE69637943D1 (fr)
DK (1) DK0959899T3 (fr)
ES (1) ES2327980T3 (fr)
PT (1) PT959899E (fr)
WO (1) WO1998007444A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003245752A1 (en) * 2002-06-28 2004-01-19 Bio Transplant, Inc. Process for promoting graft acceptance by depletion of hematopoietic stem cells
DK1534819T3 (da) 2002-08-21 2010-04-19 Revivicor Inc Griselignende dyr, som mangler enhver ekspression af funktionel alfa-1,3-galactosyltransferase
WO2005047469A2 (fr) 2003-11-05 2005-05-26 University Of Pittsburgh Proteine isogloboside 3 synthase porcine, adnc, organisation genomique, et region regulatrice
AU2005223617A1 (en) 2004-03-17 2005-09-29 Revivicor, Inc. Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
JP2023531251A (ja) * 2020-06-23 2023-07-21 ゼラリオン マルタ リミテッド 抗ｃｄ２抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2700893A (en) 1952-08-06 1955-02-01 Teddy A Kudlacik Balancing device
US4798806A (en) * 1980-01-08 1989-01-17 Ortho Pharmaceutical Corporation Compositions and methods using a monoclonal antibody to a human T cell antigen
GB9125979D0 (en) * 1991-12-06 1992-02-05 Wellcome Found Antibody
ES2164699T3 (es) * 1993-03-05 2002-03-01 Univ Catholique Louvain Anticuerpo lo-cd2a y usos del mismo para inhibir la activacion y la proliferacion de las celulas t.
CN113299700A (zh) 2021-05-08 2021-08-24 武汉华星光电半导体显示技术有限公司 一种显示面板及其制备方法

Also Published As

Publication number Publication date
AU6953296A (en) 1998-03-06
CA2262546C (fr) 2009-03-17
WO1998007444A1 (fr) 1998-02-26
ATE432080T1 (de) 2009-06-15
HK1021318A1 (en) 2000-06-09
EP0959899B1 (fr) 2009-05-27
EP0959899B9 (fr) 2009-10-21
CA2262546A1 (fr) 1998-02-26
EP0959899A1 (fr) 1999-12-01
AU737602B2 (en) 2001-08-23
PT959899E (pt) 2009-08-28
EP0959899A4 (fr) 2005-01-12
DE69637943D1 (de) 2009-07-09
JP2001521374A (ja) 2001-11-06
ES2327980T3 (es) 2009-11-05

Similar Documents

Publication Publication Date Title
DK1003552T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DK0741784T3 (da) Ligand (ACT-4-L) til en receptor på overfladen af aktiverede CD4+ T-celler
NO986173L (no) FremgangsmÕte for aktivering av dendrittceller
DE69309472D1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DK0859957T3 (da) Patientspecifikke immunadsorbenser til ekstraporal apherese og fremgangsmåde til deres fremstilling
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
NO943915L (no) Lymfocytt-aktiveringsantigen HB15, et medlem av immunoglobulin-superfamilien
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
DE60042941D1 (de) Verwendung von anti-cd3 monoklonale antikörper und il-5 zur behandlung von autoimmunkrankheiten
ATE246003T1 (de) Pharmazeutische oder nahrungsmittelzusammensetzung für die behandlung von pathologien die assoziiert sind mit einem transplantatabstoss, einer allergischen oder autoimmunreaktion
DK0959899T3 (da) LO-CD2a-antistof samt dets anvendelse til h mning af T-celleaktivering og -proliferation
NO964200L (no) Behandling av autoimmun sykdom ved anvendelse av oral tolerisering og/eller Th2-forsterkende cytokiner
DK1021196T3 (da) Anvendelse af en kemisk stabiliseret chloritoplösning til inhibering af en antigenspecifik immunreaktion
DE69637078D1 (de) Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren
DK0837672T3 (da) Præparationer og fremgangsmåder til behandling af T-cellemedierede sygdomme
HU9601981D0 (en) T cell stimulating protein of pestivirus
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
CO4820397A1 (es) TRATAMIENTO CONTRA EL ASMA CON TNFR -Ig
ATE179331T1 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78
DE69333111D1 (de) Natürliche menschliche igm antikörper
KR910006478A (ko) 인체 트립타제 유사 단백질
ATE99333T1 (de) Immunogen und seine verwendung zur gewinnung von antikoerpern gegen haemoglobin a1c.